Table 3.
Stage at diagnosis of lung cancer in developing and developed countries
| Countries | Stage at diagnosis | ||
|---|---|---|---|
|
| |||
| Stage III (%) | Stage IV (%) | ||
| LMIC | Mexico [7] | - | 98.9* |
| India [8] | 30.1 | 64.4 | |
| Peru [9] | 9.2 | 85.5 | |
| Russia [10] | A: 23.7 | 25.4 | |
| B: 14.1 | |||
| China [11] | 42.5* | ||
| Japan [12] | 26.5 | 66.3 | |
| Korea [6] | 22.9 | 42 | |
| Malaysia† | Male: 23 | Male: 66 | |
| Female: 19 | Female: 71 | ||
| HIC | U.S. [13] | A: 9.0 | 45 |
| B: 17 | |||
| U.K. [13] | A: 13 | 52 | |
| B: 12 | |||
| Canada‡ | 20 | 49 | |
LC: lung cancer; LMICs: low- and middle-income countries; HICs: high-income countries.
Stage IIIB-IV.
Azizah AB. MALAYSIAN NATIONAL CANCER REGISTRY REPORT 2007-2011. Accessed February 24, 2021. Available https://www.crc.gov.my/wpcontent/uploads/documents/report/MNCRRrepor2007-2011.pdf.
Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics: A 2020 special report on lung cancer. Toronto, ON: Canadian Cancer Society; 2020. Available at: cancer.ca/Canadian-Cancer-Statistics-2020-EN. Accessed January 20, 2021. https://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-cancer-statistics-2020_special-report_EN.pdf?la=en.